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Editorial
The neurological disorders and stroke represent the last century’s medical challenge. Despite 
increasing number of elderly people and the subsequent increase of neurological diseases, in so-
called industrialized countries, we have no efficacious strategy to fight this plague.
Probably, the more effective method to take on this challenge may be a rigorous prevention 
and principle risk factors (e.g. high-pressure, stress, obesity, smoke of tobacco and alcohol) 
elimination. On the other hand, further scientific research in this field could be very useful. This 
kind of research should be based on the use of animal models to improve current understanding of 
the pathophysiological features of these diseases and may yield important information on how to 
improve analysis of the “efficacy” of some possible molecules.
Many authors, in a number of related medical fields, have evaluated the importance of preclinical 
research and they have written different review articles. However, in these models of disease, we 
often have some problem to acknowledge a precise human disorder. For instance, an animal model 
of stroke may use the focal cerebral ischemia. Actually, this model predicts the outcome of an 
ischemic insult but, it does not reproduce the general background pathophysiological that would 
cause an endogenous stroke. Therefore, we should accept the limitations inherent in these models 
and, follow early proof of efficacy studies in “young healthy animals” with more accurate studies in 
models incorporating age and co-morbidities. Presumably, translational problems may decrease 
with further improvement in preclinical study design and conduct. 
Recent preclinical studies underline the relevance of human cell-based approach to study stroke. 
Once again, these papers evidenced the crucial role of animal models. Moreover, these models were 
also appropriate to evaluate the effects of stem cell transplantation in Ischemic Stroke. It is the 
general opinion that the advantageous clinical translation of cell-based therapy requires the use, in 
preclinical research, of scientifically appropriate and of reproducible functional neurological result 
evaluations, which are adequately sensitive to investigate sensor motor asymmetry related to the site 
of ischemia.
As a relevant outcome of the use of this approach, it should be noted that, regardless of cell type 
and delivery route, exogenous cells show targeted delivery to the infarct site. These results were 
obtained after about ten years of research in this field. The use of animals as model of stroke refers to 
different races, ages, sex and types of is chemia. Therefore, effects of age and sex on stroke incidence, 
functional neurological recovery and stroke mortality have been demonstrated both in humans 
and in animal models. In particular, the age-dependent escalation in the advancement of ischemic 
tissue into infarction, strongly hints that age is a relevant biological parameter for the variability in 
stroke outcome. Interestingly though, it appears that age plays a significant role in the neurological 
recovery via recruitment of neighboring neuronal circuitries. This invaluable information may be 
acquired through animal model studies only. That is due to the fact that, it was regularly observed 
that neurological recovery is associated with dendritic and synaptic plasticity in the contralesional 
striatum and with axonal plasticity in contralesional motor cortex. This suggests that a spontaneous 
post-stroke striatal recovery could also be increased by inputs from contra lateral striatum and could 
elucidate why patients with sub cortical stroke are more likely to exhibit spontaneous neurological 
recovery.
A detailed analysis of previous research clearly demonstrates that the contribution of animal 
model and preclinical studies to understand pathophysiological mechanisms of neurological 
disorder, stroke and its recovery, represents a pivotal piece of this puzzle. Probably, physicians, 
specialists (neurologists) and the scientific community (neuroscientists) should collaborate to 
expand our knowhow regarding these devastating diseases, which represent the second most 
common cause of death in Europe, and the third most common cause of death in the United States 
and Canada.
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